Abstract
A cysteine (Cys) activatable chlorinated hemicyanine (Cl-Cys) was introduced as a tumour selective image-guided dual phototherapy agent. Cl-Cys exhibited a significant turn on response in its near-IR emission signal and activated its singlet oxygen generation as well as photothermal conversion potentials upon reacting with Cys. The laser irradiation of Cl-Cys induced significant cell death in cancer cells with high Cys level, while it stayed deactivated and non-emissive in a healthy cell line. A profound synergistic PDT/PTT effect was observed at high doses. Remarkably, Cl-Cys marks the first ever example of Cys-responsive small organic-based therapeutic agent and holds a great promise to develop new activity-based photosensitizers for dual phototherapy action.
| Original language | English |
|---|---|
| Article number | 105725 |
| Journal | Bioorganic Chemistry |
| Volume | 122 |
| DOIs | |
| Publication status | Published - May 2022 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2022 Elsevier Inc.
Funding
SK thanks BAGEP award of Science Academy for the financial support. Authors thank Kübra Nur Özvural Sertçelik for the graphical abstract.
| Funders |
|---|
| Bilim Akademisi |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer
- Cysteine
- Hemicyanine
- Photosensitizers
- Phototherapy
- Theranostics
Fingerprint
Dive into the research topics of 'Development of a cysteine responsive chlorinated hemicyanine for image-guided dual phototherapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver